Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07449494
Eligibility Criteria:
Inclusion Criteria:
* Infertile patients undergoing IVF with planned fresh or frozen embryo transfer
* Age ≤ 40 years at the time of the transfer
* Documented uterine immune over-activation
* Treatment with glucocorticoids in routine clinical practice, with or without prior glucocorticoid sensitivity testing
* Fresh or frozen blastocyst transfer performed within 9 months following immune assessment at Hôpital des Bluets
Exclusion Criteria:
* • Age \> 40 years
* No available uterine immune profile
* Normal immune profile or immune underactivation
* Management exclusively with alternative therapeutic strategies (e.g., low molecular weight heparin \[LMWH\], intralipid therapy) or combination therapies (e.g., LMWH + glucocorticoids or intralipid + glucocorticoids)
* Embryo transfer performed more than 9 months after immune assessment
* Cleavage-stage embryo transfer
* Embryo transfer performed in another center
* Oocyte donation IVF cycles
Healthy Volunteers:
False
Sex:
FEMALE
Maximum Age:
40 Years
Study:
NCT07449494
Study Brief:
Protocol Section:
NCT07449494